BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 12675661)

  • 1. Effectiveness of screening in preventing blindness due to diabetic retinopathy.
    Arun CS; Ngugi N; Lovelock L; Taylor R
    Diabet Med; 2003 Mar; 20(3):186-90. PubMed ID: 12675661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term impact of retinal screening on significant diabetes-related visual impairment in the working age population.
    Arun CS; Al-Bermani A; Stannard K; Taylor R
    Diabet Med; 2009 May; 26(5):489-92. PubMed ID: 19646188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetic retinopathy. Screening and prevention of blindness. A doctoral thesis.
    Kristinsson JK
    Acta Ophthalmol Scand Suppl; 1997; (223):1-76. PubMed ID: 9559048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of diabetic retinopathy screening on a British district population: case detection and blindness prevention in an evidence-based model.
    Bachmann MO; Nelson SJ
    J Epidemiol Community Health; 1998 Jan; 52(1):45-52. PubMed ID: 9604041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The incidence of visual impairment due to diabetic retinopathy in Leeds.
    Kumar N; Goyder E; McKibbin M
    Eye (Lond); 2006 Apr; 20(4):455-9. PubMed ID: 15905872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blindness in patients with diabetes who have been screened for eye disease.
    Rhatigan MC; Leese GP; Ellis J; Ellingford A; Morris AD; Newton RW; Roxburgh ST
    Eye (Lond); 1999 Apr; 13 ( Pt 2)():166-9. PubMed ID: 10450375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening and prevention of diabetic blindness.
    Stefánsson E; Bek T; Porta M; Larsen N; Kristinsson JK; Agardh E
    Acta Ophthalmol Scand; 2000 Aug; 78(4):374-85. PubMed ID: 10990036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing progression and efficacy of treatment for diabetic retinopathy following the proliferative pathway to blindness: implication for diabetic retinopathy screening in Taiwan.
    Liu WJ; Lee LT; Yen MF; Tung TH; Williams R; Duffy SW; Chen TH
    Diabet Med; 2003 Sep; 20(9):727-33. PubMed ID: 12925052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Active prevention in diabetic eye disease. A 4-year follow-up.
    Kristinsson JK; Hauksdóttir H; Stefánsson E; Jónasson F; Gíslason I
    Acta Ophthalmol Scand; 1997 Jun; 75(3):249-54. PubMed ID: 9253967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of blindness by screening for diabetic retinopathy: a quantitative assessment.
    Rohan TE; Frost CD; Wald NJ
    BMJ; 1989 Nov; 299(6709):1198-201. PubMed ID: 2513049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early detection of diabetic retinopathy.
    Harper CA; O'Day J; Taylor HR
    Med J Aust; 1995 May; 162(10):536-8. PubMed ID: 7776916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The contribution of the English NHS Diabetic Eye Screening Programme to reductions in diabetes-related blindness, comparisons within Europe, and future challenges.
    Scanlon PH
    Acta Diabetol; 2021 Apr; 58(4):521-530. PubMed ID: 33830332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of sight-threatening retinopathy in Type 1 diabetes in a systematic screening programme.
    Younis N; Broadbent DM; Harding SP; Vora JP
    Diabet Med; 2003 Sep; 20(9):758-65. PubMed ID: 12925058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of and risk factors for proliferative retinopathy and its association with blindness among diabetes clinic attenders.
    Janghorbani M; Jones RB; Allison SP
    Ophthalmic Epidemiol; 2000 Dec; 7(4):225-41. PubMed ID: 11262670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of blindness and visual impairment in a population of people with diabetes.
    Prasad S; Kamath GG; Jones K; Clearkin LG; Phillips RP
    Eye (Lond); 2001 Oct; 15(Pt 5):640-3. PubMed ID: 11702977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The English national screening programme for sight-threatening diabetic retinopathy.
    Scanlon PH
    J Med Screen; 2008; 15(1):1-4. PubMed ID: 18416946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Programme preventing vision loss due to diabetes].
    Bandurska-Stankiewicz E; Wiatr D
    Klin Oczna; 2007; 109(7-9):359-62. PubMed ID: 18260299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Causes of blindness and partial sight in the Bradford Metropolitan District from 1980 to 1985.
    Yap M; Weatherill J
    Ophthalmic Physiol Opt; 1989 Jul; 9(3):289-92. PubMed ID: 2622670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of blindness due to diabetic eye disease in Fife 1990-9.
    Cormack TG; Grant B; Macdonald MJ; Steel J; Campbell IW
    Br J Ophthalmol; 2001 Mar; 85(3):354-6. PubMed ID: 11222346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology of visual impairment, sight-threatening or treatment-requiring diabetic eye disease in children and young people in the UK: findings from DECS.
    Ibanez-Bruron MC; Solebo AL; Cumberland P; Rahi JS
    Br J Ophthalmol; 2021 May; 105(5):729-734. PubMed ID: 32536608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.